BackLatigo Biotherapeutics Overview

Latigo Biotherapeutics Accounts Payable

Track Latigo Biotherapeutics's accounts payable ($5.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$5.08M

Peer trimmed avg / median

Loading

Latigo Biotherapeutics Accounts Payable History

Loading

Latigo Biotherapeutics vs. peers: Accounts Payable Comparison

Loading

Latigo Biotherapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Latigo Biotherapeutics (LTGO) FAQ

Latigo Biotherapeutics's accounts payable stands at $5.1M as of September 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Latigo Biotherapeutics's accounts payable is expanding or contracting. Sustained growth in accounts payable can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Latigo Biotherapeutics's accounts payable evolved across reporting periods, while the comparison chart places LTGO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers